Table 4.
Timeliness of treatment initiation
| Measure | Integrated | Control | P–value | |
|---|---|---|---|---|
|
Duration of ART before delivery (weeks): | ||||
| Killam 2010 [46] |
Mean (SD) |
10 (N/A) |
11 (N/A) |
NS |
| van der Merwe 2006 [40] |
Median (IQR) |
7 (3.9–11.2) |
5 (2–10) |
NS |
|
Gestational age at ART initiation (weeks): | ||||
| Killam 2010 [46] |
Mean (SD) |
22 (N/A) |
22 (N/A) |
NS |
| van der Merwe 2006 [40] |
Median (IQR) |
32 (28–35) |
33.5 (31–36) |
0.042 |
| Stinson 2013 [41] |
Median (IQR) |
31 (28–34) |
30 (27–34) |
NS |
|
Time to receiving CD4 cell count (days): | ||||
| van der Merwe 2006 [40] |
Median (IQR) |
29 (11.5–45) |
50 (22–92) |
0.047 |
|
Time to treatment initiation (days): | ||||
| Stinson 2013 [41] |
Median (IQR) |
36 (N/A) |
59 (N/A) |
<0.001 |
| van der Merwe 2006 [40] | Median (IQR) | 37 (22–63) | 56 (30–103) | 0.041 |
SD – standard deviation, IQR – interquartile range, N/A – not applicable, NS – not significant